Andelyn Biosciences Strengthens Gene Therapy Innovation with Expanded AAV Curator™ Platform

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

February 21, 2025 | Friday | News
Parse Biosciences launches high resolution kit for single cell sequencing

US-based Parse Biosciences, the leader in high-throughput single cell sequencing, has announced the launch of Evercode W...

February 20, 2025 | Thursday | News
Merck KGaA, Darmstadt, Germany, Elevates Leadership for a Future of Innovation and Growth

"This transition is a testament to our commitment to both continuity and innovation," announced Merck KGaA, Darmstadt, G...

February 19, 2025 | Wednesday | News
Japan's NEC invests in Aetion, US-based provider of healthcare analytics platforms

NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has invested in Aetion, Inc., a ...

February 19, 2025 | Wednesday | News
Pfizer Reports Strong Q4 2024 with $17.8B Revenue, Driven by Oncology and Cardiovascular Growth

Pfizer reported a strong fourth quarter (Q4) of 2024, achieving $17.8 billion in total revenues, reflecting a 21% year-o...

February 17, 2025 | Monday | Company results
Novartis Reports Strong Q4 2024 with 16% Sales Growth, Driven by Cardiovascular, Oncology, and Immunology Therapies

Novartis delivered a strong Q4 2024 performance, with net sales growing by 16% year-over-year (YoY) at constant currency...

February 17, 2025 | Monday | Company results
Moderna Reports $966M Q4 2024 Revenue Amid COVID-19 Vaccine Decline, Focuses on mRNA Pipeline Expansion

Financial Performance Overview Moderna reported Q4 2024 revenue of $966 million, marking a 66% decline year-over-year (...

February 17, 2025 | Monday | Company results
GSK Reports Strong Q4 2024 Growth in Specialty Medicines and HIV, Offsetting Vaccine Declines

GSK delivered a strong performance in Q4 2024, with total sales reaching £8.12 billion, reflecting a 4% year-over-...

February 17, 2025 | Monday | Company results
Eli Lilly Reports Record Q4 2024 Revenue of $13.53B, Fueled by Mounjaro, Zepbound, and Oncology Growth

Eli Lilly & Co. reported a strong financial performance in Q4 2024, with substantial revenue growth driven by its bl...

February 17, 2025 | Monday | Company results
Biogen Reports Q4 and Full-Year 2024 Results: Strong EPS Growth Amid Revenue Challenges

Key Financial Highlights Biogen Inc. reported its fourth-quarter (Q4) and full-year 2024 results on February 12, 2025. ...

February 17, 2025 | Monday | Company results
AstraZeneca Reports Strong Q4 2024 Growth with $14.89 Billion Revenue, Driven by Oncology and Innovative Therapies

  AstraZeneca delivered a strong performance in Q4 2024, with Total Revenue reaching $14.89 billion, marking a 24%...

February 17, 2025 | Monday | Company results
Zydus and Beihai Biotech ink agreement to supply oncology drug to US market

  Indian pharmaceutical firm Zydus Lifesciences has announced that its wholly owned subsidiary, Zydus Lifesciences...

February 15, 2025 | Saturday | News
Korea's Hanmi Pharma introduces new automated vial dispensing solution in Canada and US

South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides ...

February 15, 2025 | Saturday | News
Thermo Fisher introduces Invitrogen EVOS S1000 Spatial Imaging System

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Invitrogen EVOS S1000 Spatial Ima...

February 13, 2025 | Thursday | News
Zydus and Synthon to commercialise novel 505(B)(2) oncology product in US market

India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...

February 12, 2025 | Wednesday | News
Japan's PHC partners with CCRM in Canada to develop primary T-cell expansion culture processes

Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...

February 10, 2025 | Monday | News
BD announces intent to separate biosciences and diagnostic solutions business

BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in the US, has announ...

February 6, 2025 | Thursday | News
Abu Dhabi selects Guardant Health’s Shield Test for blood-based colorectal cancer screening programme

US-based Guardant Health, Inc., a leading precision oncology company, has announced an agreement with the Abu Dhabi Publ...

January 31, 2025 | Friday | News